This allows each to carry similar efficacy and most people wanting to avoid injections have no issues administering the drops daily
For example, if you started a GLP-1 in September 2024 with a BMI of 37 but in July 2026 youve lost weight and now have a BMI of 34, the prescriber should attest in the prior authorization request that you met the BMI criteria of 35 or over when the GLP-1 therapy started
During a race, the body accumulates metabolic sludge, i.e., lactic acid, ammonia, and oxidized proteins
The Centers for Medicare & Medicaid Services has not yet announced plans to restart or restructure its longer-term plan to integrate coverage into Part D after that date
Some plans may approve a trial period of three to six months with specific weight loss targets
Doses of sitagliptin up to 125 mg/kg (approximately 12 times the human exposure at the maximum recommended human dose) did not impair fertility or harm the fetus